Back to search results

Study of Carboplatin and Mirvetuximab Soravtansine in First-Line Treatment of Patients Receiving Neoadjuvant Chemotherapy With Advanced-Stage Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Abroad (travel likely)RecruitingPHASE2

Conditions

Ovarian Cancer · Fallopian Tube · Primary Peritoneal Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • University of Alabama at Birmingham Womens & Infants Center, Birmingham, Alabama, United States

    Contact: Study coordinator (Rebecca Arend)

  • University of California San Francisco, San Francisco, California, United States

    Contact: Study coordinator (Jocelyn Chapman, MD) · jocelyn.chapman@ucsf.edu · 415-353-9600

  • University of Minnesota - Masonic Cancer Center, Minneapolis, Minnesota, United States

    Contact: Study coordinator (Britt Erickson, MD) · bkeric@umn.edu · 612-676-4200

  • Mayo Clinic, Rochester, Minnesota, United States

    Contact: Study coordinator (Andrea Hendrickson, MD) · wahnerhendrickson.andrea@mayo.edu · 507-284-2511

  • University of Mississippi Medical Center, Oxford, Mississippi, United States

    Contact: Study coordinator (Rodney Rocconi, MD) · rocconi@umc.edu · 251-435-2273

  • Ohio State University, Columbus, Ohio, United States

    Contact: Study coordinator (David O'Malley, MD) · davidomalley@osumc.edu · 614-688-9220

  • University of Oklahoma, Oklahoma City, Oklahoma, United States

    Contact: Study coordinator (Debra Richardson, MD) · debra-richardson@ouhsc.edu · 405-271-8707

  • Allegheny Health Network, Pittsburgh, Pennsylvania, United States

    Contact: Study coordinator (Thomas Krivack, MD) · thomas.krivak@ahn.org · 412-578-1116

  • University of Virginia, Richmond, Virginia, United States

    Contact: Study coordinator (Marilyn Huang, MD) · msh8f@uvhealth.org · 434-924-5100
Study leads

  • Rebecca Arend, M.D.

    Principal Investigator

    University of Alabama at Birmingham

View source on ClinicalTrials.gov(opens in a new tab)